3/7 🎯 Portfolio Optimization
SPARC is focusing on Oncology &amp; Immunology with SCD-153 &amp; SBO-154 as anchor assets. A flexible business model for early partnerships is also in the works! #Oncology #Immunology
#Oncology #Immunology